Please Wait a Moment
X

CTS History

01Jul

Research Consortium

SuperUser Account |01 Jul, 2013 | Return|

CTS Research Consortium was established to further CTS’s leadership in infectious disease research. This collaboration between Vitalant Research Institute, Carter BloodCare, OneBlood, ITxM, New York Blood Center and Bloodworks Northwest will provide a wealth of data for the development of future hypothesis-based research studies. 

About the Author

Related

Pooled Babesia

Pooled Babesia

Transitioned all 5 CTS labs from an investigational new drug (IND) to a licensed pooled Babesia test...

Read More >
CTS merges with the three Red Cross testing laboratories

CTS merges with the three Red Cross testing laboratories

CTS merges with the three Red Cross testing laboratories located in Charlotte, Portland and St. Loui...

Read More >
Implementation of a COVID-19 Test

Implementation of a COVID-19 Test

CTS Tampa lab implemented the Ortho Clinical Diagnostics VITROS® testing platform to perform COVID-1...

Read More >
CTS implements licensesd Zika test

CTS implements licensesd Zika test

Transitioned all 6 CTS labs from an investigational new drug (IND) to a licensed Zika test, and anno...

Read More >
Source Plasma Testing

Source Plasma Testing

In August CTS begins source plasma testing as a new line of business to one of the largest plasma fr...

Read More >
CTS Founded

CTS Founded

In January, CTS is incorporated as a non-profit organization owned by Vitalant and OneBlood (formerl...

Read More >